Ruxolitinib inhibits poly(I:C) and type 2 cytokines‐induced CCL5 production in bronchial epithelial cells: A potential therapeutic agent for severe eosinophilic asthma-Reference-Cited by-同舟云学术

Ruxolitinib inhibits poly(I:C) and type 2 cytokines‐induced CCL5 production in bronchial epithelial cells: A potential therapeutic agent for severe eosinophilic asthma

Published:2021-02-03 Issue:2 Volume:9 Page:363-373
ISSN:2050-4527
Container-title:Immunity, Inflammation and Disease
language:en
Short-container-title:Immun Inflamm Dis

Author:

Sada Mitsuru¹^ORCID,Watanabe Masato¹^ORCID,Inui Toshiya¹,Nakamoto Keitaro¹^ORCID,Hirata Aya¹,Nakamura Masuo¹,Honda Kojiro¹,Saraya Takeshi¹^ORCID,Kurai Daisuke²,Kimura Hirokazu³,Ishii Haruyuki¹^ORCID,Takizawa Hajime¹^ORCID

Affiliation:

1. Department of Respiratory Medicine Kyorin University School of Medicine Tokyo Japan

2. Division of Infectious Diseases, Department of General Medicine, School of Medicine Kyorin University Tokyo Japan

3. Department of Health Science Graduate School of Health Science, Gunma Paz University Gunma Japan

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/iid3.397

Reference64 articles.

1. Asthma GIf. Global strategy for the diagnosis and prevention. Global Initiative for Asthma. 2018.

2. Current concepts of severe asthma

3. Severe and Difficult-to-Treat Asthma in Adults

4. Involvement and Possible Role of Eosinophils in Asthma Exacerbation

5. Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells;Frontiers in Immunology;2024-08-12

2. Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A viruses;PLOS Pathogens;2024-07-22

3. Disrupting TSLP–TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases;EMBO Molecular Medicine;2024-06-14

4. Distinct Effects of Respiratory Viral Infection Models on miR-149-5p, IL-6 and p63 Expression in BEAS-2B and A549 Epithelial Cells;Cells;2024-05-26

5. Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A viruses;2024-02-03